| Clinical Care Options 2004-08-03, 6:51 pm |
| CCO UPDATE
In this issue:
Lessons Learned: Use of HIV Drug Resistance Testing in Treatment
Failure
http://clinicaloptions.com/HIVlessons10315
Virtual Presentations: CROI Update 2004
http://clinicaloptions.com/CROIslides0315
All programs are free to access, after completing a short, one-time
registration.
Edward King
Editorial Director
hiveditor@imedoptions.com
_________________
Editorial suggestions or comments? Email hiveditor@imedoptions.com
Technical problems with the site? Email techhelp@imedoptions.com
ONLINE CME
Lessons Learned: Use of HIV Drug Resistance Testing in Treatment
Failure
http://clinicaloptions.com/HIVlessons10315
A 6-part CME series reflecting on past missteps in the clinical
management of HIV-infected patients, and how these have advanced our
understanding of optimal treatment strategies. Check back each month
for the next lesson!
In the first installment, William A. O'Brien, MD, MS reviews our
evolving understanding of the management of patients experiencing
virologic failure, including the appropriate use and interpretation of
resistance tests, and the importance of taking the overall treatment
history into consideration
VIRTUAL PRESENTATIONS
CROI Update 2004
http://clinicaloptions.com/CROIslides0315
Now available: A unique Internet-based CME activity offering two
options:
1. Watch and hear the experts present three PowerPoint presentations:
+ Management of Treatment-Naive Patients: Kimberly Y. Smith,
MD, MPH
+ Resistance, Treatment Strategies, and New Agents: Joseph
J. Eron Jr, MD
+ Metabolic Complications and Coinfections: William G.
Powderly, MD
2. Download a complete 60-slide "CROI Update" PowerPoint deck with
full speaker's notes for your own use
CONFERENCE COVERAGE
11th Conference on Retroviruses and Opportunistic Infections
February 8-11, 2004; San Francisco, California
http://clinicaloptions.com/croi0315
Now available: Next-day news reports and Capsule Summaries of the key
studies, organized in 5 tracks. Coming soon: CME-certified Expert
Analyses of the clinical implications.
* Management of Treatment-Naive Patients
Joel E. Gallant, MD, MPH; W. David Hardy, MD; Kimberly Y. Smith,
MD, MPH
* Resistance, Salvage Therapy, and Treatment Strategies
Joseph J. Eron Jr, MD; Daniel R. Kuritzkes, MD; Andrew R. Zolopa,
MD
* Metabolic Complications and Lipodystrophy
Donald P. Kotler, MD; William G. Powderly, MD; Kathleen E.
Squires, MD
* Pharmacology and Adverse Drug Effects
Stephen L. Becker, MD; Courtney V. Fletcher, PharmD; Charles W.
Flexner, MD
* Hepatitis Coinfection and Opportunistic Infections
Richard E. Chaisson, MD; Bruce Polsky, MD; William G. Powderly, MD
RECENT NEWS REPORTS
http://clinicaloptions.com/hivnews040315
* NRTI toxicity may be associated with increased cellular activation
due to advanced disease
* Surgical options provide good long-term improvement in buffalo
hump
* Persistent HIV/hepatitis G coinfection provides significant
survival benefits
* Protein discovered that blocks HIV in monkeys: potential for
vaccine and treatment research
* Adherence, not baseline CD4+ cell count, linked to CD4+ cell gain
on HAART
OTHER RECENTLY PUBLISHED PROGRAMS
HIV/AIDS Annual Update 2003
http://clinicaloptions.com/hivupdate20030315
Top 10 HIV/AIDS Research Advances of 2003
http://clinicaloptions.com/hivevjan040315
Failure of a Once-Daily Triple-NRTI Combination of Abacavir/Lamivudine
Plus Tenofovir DF
http://clinicaloptions.com/hivevdec030315
9th European AIDS Conference
http://clinicaloptions.com/eacs0315
All Clinical Care Options for HIV content is free to use and available
to everyone after a quick, one-time registration process.
If you do not wish to receive future announcements about Clinical Care
Options programs, please send an email to info@imedoptions.com.
(c) 2004 by iMedOptions, LLC, PO Box 1772, Ashburn, VA 20146-1772
|